PAR

Par Drugs & Chemicals Share PricePar Drugs & Chemicals

₹210.35
3.55 (1.72%)
As on 10 June, 2023 | 17:37 BSE: NSE: PAR

Par Drugs & Chemicals Performance

Day Range

  • Low
  • High
210.35

52 Week Range

  • Low
  • High
210.35
  • Open Price
  • Previous Close
  • Volume

Start SIP in Par Drugs & Chemicals

Start SIP

Par Drugs & Chemicals Share Price

  • Over 1 Month 26.98%
  • Over 3 Month 37.26%
  • Over 6 Month 34.58%
  • Over 1 Year 46.43%

Par Drugs & Chemicals Key Statistics

P/E Ratio 22.8
PEG Ratio 1
Market Cap Cr 259
Price to Book Ratio 3.6
EPS 9.2
Dividend 0
Relative Strength Index 67.03
Money Flow Index 38.27
MACD Signal 10.98
Average True Range 8.35

Par Drugs & Chemicals Investment Rating

  • Master Rating:
  • Par Drugs and Chemicals has an operating revenue of Rs. 95.75 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of 16% is great, ROE of 15% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 20% and 30% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 5% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 83 which is a GOOD score indicating consistency in earnings, a RS Rating of 81 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 113 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has great fundamentals and technical strength to stay in momentum.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Par Drugs & Chemicals Financials
IndicatorMar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 2423252422
Operating Expenses Qtr Cr 1920192018
Operating Profit Qtr Cr 53645
Depreciation Qtr Cr 11111
Interest Qtr Cr 00000
Tax Qtr Cr 11111
Net Profit Qtr Cr 32422

Par Drugs & Chemicals Technicals

EMA & SMA

Current Price
₹210.35
3.55 (1.72%)
  • Bullish Moving Average
  • ___
  • 16
  • Bearish Moving Average
  • ___
  • 0
  • 20 Day
  • ₹200.51
  • 50 Day
  • ₹183.34
  • 100 Day
  • ₹171.61
  • 200 Day
  • ₹164.66
  • 20 Day
  • ₹202.79
  • 50 Day
  • ₹175.15
  • 100 Day
  • ₹164.14
  • 200 Day
  • ₹161.11

Par Drugs & Chemicals Resistance and Support

PIVOT
₹209.87
Resistance
First Resistance ₹214.64
Second Resistance ₹218.92
Third Resistance ₹223.69
RSI 67.03
MFI 38.28
MACD Single Line 10.98
MACD 9.81
Support
First Resistance ₹205.59
Second Resistance ₹200.82
Third Resistance ₹196.54

Par Drugs & Chemicals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 34,833 2,673,084 76.74
Week 21,439 1,533,975 71.55
1 Month 42,775 2,363,339 55.25
6 Month 20,779 1,132,658 54.51

Par Drugs & Chemicals Result Highlights

Par Drugs & Chemicals Synopsis

NSE-Medical-Diversified

Par Drugs & Chemical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 95.75 Cr. and Equity Capital is Rs. 12.30 Cr. for the Year ended 31/03/2023. Par Drugs & Chemicals Ltd. is a Public Limited Listed company incorporated on 26/02/1999 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24117GJ1999PLC035512 and registration number is 035512.
Market Cap 259
Sales 96
Shares in Float 0.32
No of funds
Yield 0.72
Book Value 3.64
U/D Vol ratio 2.7
LTDebt / Equity
Alpha 0.18
Beta 0.24

Par Drugs & Chemicals

Owner NameMar-23Dec-22Sep-22Jun-22
Promoters 74.21%74.21%74.21%74.21%
Mutual Funds
Insurance Companies
Foreign Portfolio Investors
Financial Institutions/ Banks
Individual Investors 22.05%21.98%
Others 3.74%3.81%25.79%25.79%

Par Drugs & Chemicals Management

Name Designation
Mr. Falgun Vallabhbhai Savani Chairman & Managing Director
Mr. Jignesh Vallabhbhai Savani Executive Director & CEO
Mr. Ghanshayambhai Bhagvanbhai Savani Whole Time Director
Mrs. Nayna Jignesh Savani Non Executive Director
Mr. Pravin Manjibhai Bhayani Independent Director
Mrs. Kajal Chintanbhai Vaghani Independent Director
Mr. Krishna Mitulbhai Shah Independent Director
Mrs. Bintal Bhaveshkumar Shah Independent Director

Par Drugs & Chemicals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Par Drugs & Chemicals Corporate Action

Date Purpose Remarks
2023-04-27 Audited Results
2023-02-10 Quarterly Results
2022-11-09 Quarterly Results
2022-07-28 Others
2022-05-07 Audited Results
Date Purpose Remarks
2021-04-28 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.

Par Drugs & Chemicals FAQs

What is Share Price of Par Drugs & Chemicals ?

Par Drugs & Chemicals share price is ₹210 As on 10 June, 2023 | 17:23

What is the Market Cap of Par Drugs & Chemicals ?

The Market Cap of Par Drugs & Chemicals is ₹258.8 Cr As on 10 June, 2023 | 17:23

What is the P/E ratio of Par Drugs & Chemicals ?

The P/E ratio of Par Drugs & Chemicals is 22.8 As on 10 June, 2023 | 17:23

What is the PB ratio of Par Drugs & Chemicals ?

The PB ratio of Par Drugs & Chemicals is 3.6 As on 10 June, 2023 | 17:23

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number